Abstract
To the Editor.— Dr. William's criticism (222:486, 1972) of the recent article entitled Combination Chemotherapy of Hodgkin's Disease in Private Practice (221:261, 1972) is illconsidered. Much of medicine is complex, and the complexity of the MOPP therapy (mechlorethamine hydrochloride, vincristine sulfate, procarbazine hydrochloride, and prednisone) for Hodgkin's disease is no less complex when administered in the setting of the university hospital than when given at the community level. All therapy, whether given for malignant disease or not, must be administered by a physician well-versed in the pharmacology of the drugs he is using. To envelop medical oncology in an aura of hypersophistication is undesirable and does much to reinforce the uninformed medical practitioner's attitude that antineoplastic agents are poisons. I am quite confident that many more people die each year of digitalis intoxication than from antineoplastic agents. I am sure there are also many patients from whom cancer chemotherapy has been
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
